VivoSim Labs (VIVS) Other Non-Current Assets (2011 - 2026)
VivoSim Labs (VIVS) posted Other Non-Current Assets of $143000.0 for Q2 2026, little changed on a QoQ basis from $143000.0 in Q1 2026, and little changed year-over-year from $143000.0 in Q2 2025.
Powered by 
Analysis
VivoSim Labs (VIVS) Other Non-Current Assets (2011 - 2026) Analysis & Trends
VivoSim Labs has reported Other Non-Current Assets for 16 years, with the latest figure at $143000.0 in Q2 2026.
- On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $143000.0 in Q2 2026; TTM through Jun 2026 was $143000.0, a 0.0% change from a year earlier, with the FY2026 full-year figure at $143000.0, changed 0.0% from the prior year.
- Other Non-Current Assets was $143000.0 for Q2 2026 at VivoSim Labs, roughly flat from $143000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $805000.0 in Q1 2022, with the low at $143000.0 in Q2 2022.
- Average Other Non-Current Assets over 5 years is $209277.8, with a median of $143000.0 recorded in 2022.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets climbed 28.83% in 2022, then tumbled 52.65% in 2025.
- Over 5 years, Other Non-Current Assets stood at $143000.0 in 2022, then changed by 0.0% to $143000.0 in 2023, then changed by 0.0% to $143000.0 in 2024, then changed by 0.0% to $143000.0 in 2025, then changed by 0.0% to $143000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $143000.0 (Q2 2026), $143000.0 (Q1 2026), and $143000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 558.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 25.20 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 117.41 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 587.56 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 91.80 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.28 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 87.48 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 201,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 91,801.74 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 143,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 143,000.00 |
| Mar 31, 2026 | 143,000.00 |
| Dec 31, 2025 | 143,000.00 |
| Sep 30, 2025 | 143,000.00 |
| Jun 30, 2025 | 143,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Dec 31, 2024 | 143,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 143,000.00 |
| Mar 31, 2024 | 302,000.00 |
| Dec 31, 2023 | 143,000.00 |
| Sep 30, 2023 | 143,000.00 |
| Jun 30, 2023 | 143,000.00 |
| Mar 31, 2023 | 515,000.00 |
| Dec 31, 2022 | 143,000.00 |
| Sep 30, 2022 | 143,000.00 |
| Jun 30, 2022 | 143,000.00 |
| Mar 31, 2022 | 805,000.00 |
| Dec 31, 2021 | 143,000.00 |
| Sep 30, 2021 | 111,000.00 |